[This review was originally posted at the Nieman Journalism Lab Tramadol Mg, on January 27, 2012.]
Google, social search, privacy, and evil: Two weeks after Google raised the ire of Facebook and Twitter by privileging Google+ within its search results, the two companies came out with a sharp response: A browser bookmarklet, developed by engineers at the two companies and MySpace and not-so-subtly titled "Don't Be Evil," that removes the specific Google+ elements of Google's new Search Plus Your World feature. Search Engine Land's Danny Sullivan has a thorough explanation of what the tool does, and search veteran John Battelle described what this "well-timed poke in the eye" means within Silicon Valley.
Some tech bloggers agreed with the sentiment behind the new hack: PandoDaily's Sarah Lacy said Google needs to acknowledge to its users that it's no longer presenting unbiased and objective search results, and her colleague MG Siegler and Daring Fireball's John Gruber argued that Google's big problem isn't ethical but practical — it's damaging its product by making results less relevant. Tramadol coupon, Others didn't see Google as the villain in this situation: Tech entrepreneur Chris Dixon argued that Twitter is asking for a sweetheart deal — top Google search rankings for their information without giving Google firehose access to it. Om Malik and Mathew Ingram of GigaOM pointed out that Facebook's record in putting user needs before its own gain is pretty spotty itself. Danny Sullivan proposed a truce between Google, Facebook, and Twitter based on making users' public information public to any search engine, treating social action as proprietary and profiles as search metadata, and making contacts portable, Tramadol pharmacy.
The obvious question here is, as Mathew Ingram framed it, will all this information sharing be good for users, Tramadol wiki, or just Google's advertisers. Gizmodo's Mat Honan led the way in charging the latter, saying that Google is taking away the user control that helped form the cornerstone of its "don't be evil" philosophy. Devin Coldewey of TechCrunch and Christopher Dawson of ZDNet argued the opposite, that Google is only simplifying its privacy policies, something that should be easier to understand and maybe even more helpful for users.
Danny Sullivan's response was mixed, Tramadol for sale, as he pointed out both potential benefits and concerns for users. Tramadol Mg, That ambivalence was shared by Wired's Tim Carmody, who concluded that Google is not evil, but "something else, something more than a little uncanny, something that despite conjecture, projections, fictions, and a combination of excitement and foreboding, we haven’t fully prepared ourselves to recognize yet."
Elsewhere in the Google empire, Google+ announced a change to its real-names-based policy, allowing "established pseudonyms." ZDNet's Violet Blue noted that the allowance of pseudonyms is still quite limited, and Trevor Gilbert of PandoDaily said this change is probably related to Google+ pseudonyms' value in Google's new integrated social search function. Adam Shostack of Emergent Chaos argued that the initial insistence on real names was a big part of Google+'s disappointing start.
Ensuring accuracy in breaking news: We saw an interesting case study in breaking news, accuracy, Cheap Tramadol no rx, and Twitter last weekend when the death of longtime Penn State football coach Joe Paterno was falsely reported Saturday night by a Penn State student news site called Onward State, then spread across Twitter. (Paterno died the following morning.) Jeff Sonderman of Poynter put together a useful Twitter timeline of the mishap, which prompted an apology and resignation by the site's managing editor, Devon Edwards, though he'll stay on staff there, Tramadol no prescription. Some other news organizations that repeated the error, most prominently CBSSports.com, published their own apologies, too.
The following day, Onward State explained how the error occurred — one reporter got an email that turned out to be a hoax, and another reporter was dishonest in his confirmation of it, Tramadol Mg. Tramadol from canada, Daniel Victor of ProPublica gave a more detailed account with some background about how the site has combined reporting and aggregation. Poynter's Craig Silverman gave a parallel explanation of how the AP decided not to run with the report.
Silverman also reviewed the aftermath of the erroneous report, concluding that journalists are too focused on the benefits of reporting news first, without looking enough at the risk. He chastised CBS Sports for not crediting Onward State with the scoop, buy Tramadol no prescription, but then passing it off on them when the story was shown to be false. Sports blogger Clay Travis said CBS' dubious behavior — particularly running with an unconfirmed bombshell report without linking to the source — was a Tramadol Mg, function of "search whoring," a tactic he said is running rampant in sports journalism.
GigaOM's Mathew Ingram went easier on Onward State, saying their process wasn't much different from that of established news orgs and praising them for their quick corrections and transparency. King Kaufman of the sports blog network Bleacher Report may have drawn the simplest, Purchase Tramadol for sale, best lesson out of all of this: "Only report what you know to be true, and tell your audience how you know it." And while writing about an unrelated story, the Lab's Gina Chen gave some other tips on bringing clarity to breaking news in a real-time environment.
Lessons from the SOPA/PIPA fight: The web declared victory last Friday in the fight over SOPA and PIPA with the postponement of both bills, then shifted promptly to postmortem mode for much of this week. Talking Points Memo's Carl Franzen had a great account of how all this happened, Tramadol cost, and New York magazine's Will Leitch said this was a seminal moment in the ascendancy of the web's ethic of collaborative creation above Hollywood's traditional gatekeeping model.
On the What It All Means front, one post stands out: Renowned Harvard network scholar Yochai Benkler's seven lessons from the SOPA/PIPA fight, in which he explained the tension between Hollywood's desire for increased copyright control and freedom of the web that gives rise to the networked public sphere, Tramadol Mg. Last week's events, he wrote, gave a glimpse of the power of that networked public, Where can i order Tramadol without prescription, which he argued is more legitimate than the power of money: "if the industry wants to be able to speak with the moral authority of the networked public sphere, it will have to listen to what the networked public is saying and understand the political alliance as a coalition."
Several others, including the Guardian's Dan Gillmor, also warned of the entertainment industry's lust for control and the copyright fights that will continue to flow out of that desire. NYU prof Clay Shirky argued this point most forcefully, cautioning us not to underestimate how far the industry will go to regain its control, rx free Tramadol, and Instapaper founder Marco Arment told us not to underestimate how much the industry loathes assertive users: "They see us as stupid eyeballs with wallets, and they are entitled to a constant stream of our money." Venture capitalist Fred Wilson was more positive in his assessment of what's next, urging the entertainment and tech industries to come together under a set of shared goals and principles.
Reading roundup: Several other ongoing discussions were still on slow burn this week. Tramadol dangers, Here's a quick review of those:
— New York Times public editor Arthur Brisbane issued his formal follow-up to his much-maligned "truth vigilantes" column, saying that he's OK with the Times doing routine fact-checking and rebutting of officials' false claims in news articles, as long as it does so very carefully and cautiously. Brisbane also stated his case Tramadol Mg, on CNN's Reliable Sources, and NPR ombudsman Edward Schumacher-Matos examined the issue as well. Voice of San Diego, meanwhile, published its own manifesto for truth vigilantism, effects of Tramadol.
— Textbooks for Apple's newly updated iBooks platform are flying off the digital shelves, though concerns about rights issues are lingering. John Gruber explained how different Apple's proprietary file format looks depending on where you're coming from, and Cult of Mac's Mike Elgan argued against Apple's rights critics. Tramadol brand name, Here at the Lab, Matthew Battles said it'll take a lot more than Apple to fix what's wrong with education publishing.
— A Pew report found that tablet and e-reader ownership nearly doubled over the holidays, Tramadol Mg. As the New York Times explained, growth was particularly strong among women, the wealthy, and the highly educated. The Atlantic's Megan Garber wondered if the gift-giving bump is really as good as it seems for Apple and Amazon.
— A few interesting pieces on online sharing: Reuters' Felix Salmon reflected on how it will disrupt the web's traditional model, and Poynter's Jeff Sonderman wrote a guide to making news content shareable. The Lab's Justin Ellis also gave some engagement tips based on Facebook data, and ProPublica's Daniel Victor looked at the viral success of images on Facebook. Researcher Nick Diakopoulos crunched some New York Times numbers to see what news gets shared on Twitter.
Similar posts: Cephalexin Dosage. Order Bactrim. Flagyl Dosage. Cephalexin coupon. Synthroid canada, mexico, india. Purchase Cipro for sale.
Trackbacks from: Tramadol Mg. Tramadol Mg. Tramadol Mg. Tramadol samples. Order Tramadol from mexican pharmacy. Tramadol from canadian pharmacy.
[This review was initially posted at the Nieman Journalism Lab Order Bactrim, on January 13, 2012.]
Social search and competition: Google made a major move toward unifying search and social networks (particularly its own) this week by fusing Google+ into its search and deepening its search personalization based on social information. It's a significant development with a lot of different angles, so I'll try to hit all of them as understandably as I can.
As usual, Search Engine Land's Danny Sullivan put together the best basic guide to the changes, with plenty of visual examples and some brief thoughts on many of the issues I'll cover here. TechCrunch's Jason Kincaid explained that while these changes may seem incremental now, low dose Bactrim, they're foreshadowing Google's eventual goal to become "a search engine for all of your stuff."
PaidContent's Jeff Roberts liked the form and functionality of the new search, but said it still needs a critical mass of Google+ activity to become truly useful, while GigaOM's Janko Roettgers said its keys will be photos and celebrities. ReadWriteWeb's Jon Mitchell was impressed by the non-evilness of it, particularly the ability to turn it off. Farhad Manjoo of Slate said Google's reliance on social information is breaking what was a good search engine, Order Bactrim. Comprar en línea Bactrim, comprar Bactrim baratos, Of course, the move was also quite obviously a shot in the war between Google and Facebook (and Twitter, as we'll see later): As Ars Technica's Sean Gallagher noted, Google wants to one-up Facebook's growing social search and keep some of its own search traffic out of Facebook. Ben Parr said Facebook doesn't need to worry, though Google has set up Google+ as the alternative if Facebook shoots itself in the foot.
But turning a supposedly neutral search engine into a competitive weapon didn't go over well with a lot of observers, generic Bactrim. The Atlantic's Alexis Madrigal saw a conflict between Google's original mission (organizing the world's information) and its new social mission, and Danny Sullivan said Google is putting score-settling above relevance. Several others sounded similar alarms: Mathew Ingram of GigaOM said users are becoming collateral damage Order Bactrim, in the war between the social networks, and web veteran John Battelle argued that the war was bad for Google, Facebook, and all of us on the web. "The unwillingness of Facebook and Google to share a public commons when it comes to the intersection of search and social is corrosive to the connective tissue of our shared culture," he wrote.
For others, the changes even called up the specter of antitrust violations. MG Siegler said he doesn't mind Google's search (near-) monopoly, but when it starts using that monopoly to push its other products, Bactrim no rx, that's when it turns into a legal problem. Danny Sullivan laid out some of the areas of dispute in a possible antitrust case and urged Google to more fully integrate its competitors into search.
Twitter was the first competitor to voice its displeasure publicly, releasing a statement arguing that deprioritizing Twitter damages real-time search. (TechCrunch has the statement and some valuable context.) Google responded by essentially saying, "Hey, you dumped us, Bactrim pictures, buddy," and its executive chairman, Eric Schmidt, told Search Engine Land they'd be willing to negotiate with Twitter and Facebook.
Finally, some brief journalistic implications: Poynter's Jeff Sonderman said this means SEO's value is waning for news organizations, being replaced by the growing importance of building strong social followings and making content easy to share, and Mathew Ingram echoed that idea, Order Bactrim. Daniel Victor of ProPublica had some wise thoughts on the meaning of stronger search for social networks, Bactrim reviews, concluding that "the key is creating strategies that don’t depend on specific tools. Don’t plan for more followers and retweets; plan for creating incentives that will gather the most significant contributions possible from non-staffers."
Innovation and its discontents: Washington Post ombudsman Patrick Pexton inducing a bit of eye-rolling among digital media folks this week with a column arguing that the paper is "innovating too fast" by overwhelming readers and exhausting employees with a myriad of initiatives that lack a coherent overall strategy. J-prof Jay Rosen followed up with a revealing chat with Pexton that helps push the discussion outside of the realm of stereotypes: Pexton isn't reflexively defending the status quo (though he remains largely print-centric), but thinks there are simply too many projects being undertaken without an overarching philosophy about how or why things should be done.
Pexton got plenty of push-back, not least from the Post's own top digital editor, Raju Narisetti, who responded by essentially saying, where can i buy cheapest Bactrim online, in Rosen's paraphrase, "This is the way it’s going to be and has to be, if the Post is to survive and thrive. It may well be exhausting but there is no alternative." GigaOM's Mathew Ingram said he was just about to praise the Post for its bold experimentation, and the Guardian's Martin Belam argued that Pexton is actually critiquing newness, Online buying Bactrim, rather than innovation.
J-prof Alfred Hermida argued Order Bactrim, — as Pexton himself seemed to in his chat with Rosen — that the issue is not about how fast or slow innovation is undertaken, but whether that innovation is done in a way that's good or bad for journalism. Former Sacramento Bee editor Melanie Sill responded that many newspapers remain stuck in 20th-century formulas, blinding them to the fact that what they consider revolutionary change is only a minor, outmoded shift. She noted that all the former top editors she's talked to have had the same regret: that they hadn't pushed harder for change. And Free Press' Josh Stearns pointed out that we should expect the path toward that change to be an easy one.
'Truth vigilantes' and objectivity: Pexton wasn't the only ombudsman this week to be put on the defensive after a widely derided column: New York Times public editor Arthur Brisbane drew plenty of criticism yesterday when he asked whether Times reporters should call out officials' untruths in their stories — or, as he put it, where to buy Bactrim, act as a "truth vigilante." Much of the initial reaction was a variation of, "How is this even a question?"
Brisbane told Romenesko that he wasn't asking whether the Times should fact-check statements and print the truth, but whether reporters should "always rebut dubious facts in the body of the stories they are writing." He reiterated this in a follow-up, in which he also printed a response by Times executive editor Jill Abramson saying the Times does this all the time. Her point was echoed by former Times executive editor Bill Keller and PolitiFact editor Bill Adair, Buy Bactrim from mexico, and while he called the initial question "stupid," Reuters' Jack Shafer pointed out that Brisbane isn't opposed to skepticism and fact-checking.
The American Journalism Review's Rem Rieder enthusiastically offered a case for a more rigorous fact-checking role for the press, as did the Online Journalism Review's Robert Niles (though his enthusiasm was with tongue lodged in cheek), Order Bactrim. The Atlantic's Adam Clark Estes used the episode as an opportunity to explain how deeply objectivity is ingrained in the mindset of the American press, pointing to the "view from nowhere" concept explicated by j-prof Jay Rosen. Rosen also wrote about the issue himself, arguing that objectivity's view from nowhere has surpassed truthtelling as a priority among the press.
How useful is the political press?: The U.S, buy Bactrim online no prescription. presidential primary season is usually also peak political-journalism-bashing season, but there were a couple of pieces that stood out this week for those interested in the future of that field. The Washington Post's Dana Milbank mocked Order Bactrim, the particular pointlessness of this campaign's reporting, describing scenes of reporters vastly outnumbering locals at campaign events and remarking, "if editors knew how little journalism occurs on the campaign trail, they would never pay our expenses."
The New Yorker's John Cassidy defended the political press against the heat it's been taking, arguing that it still produces strong investigative and long-form reporting on important issues, and that the speed of the new news cycle allows it to correct itself quickly. He blamed many of its perceived failings not on the journalists themselves, but on the public that's consuming their work.
The Boston Phoenix reported on the decline of local newspapers' campaign coverage and wondered if political blogs and websites could pick up the slack, Bactrim use, while the Lab's Justin Ellis looked at why news orgs love partnering up during campaign season, focusing specifically on the newly announced NBC News-Newsweek/Daily Beast arrangement.
A unique paywall model: The many American, British, and Canadian publishers implementing or considering paywalls might marvel at the paid-content success of Piano Media, but they can't hope to emulate it: A year after gaining the cooperation of each of Slovakia's major news publishers for a unified paywall there, the company is expanding the concept to Slovenia, no prescription Bactrim online. As paidContent noted, Piano is hoping to sign up 1% of Slovenia's Internet-using population, and the Lab's Andrew Phelps reported that the company is planning to bring national paywalls to five European nations by the end of the year. As Piano's CEO told Phelps, the primary barrier to subscription has not been economic, but philosophical, especially for commenting, Order Bactrim.
Elsewhere in paywalls, media consultant Frederic Filloux looked at what's making the New York Times' strategy work so far — unique content, Bactrim results, a porous paywall that allows it to maintain high traffic numbers and visibility, and cooperation with Apple — and analyst Ken Doctor wondered whether all-access subscriptions across multiple devices and publications within a company could be a key to paid content this year.
Reading roundup: Tons of smaller stuff going on this week outside the glare of the Google-Facebook-Twitter wars. Here's a quick rundown:
— One item I forgot to note from late last week: The AP and a group of 28 other news organizations have launched NewsRight, a system to help news orgs license their content to online aggregators. Poynter's Rick Edmonds offered a detailed analysis, but GigaOM's Mathew Ingram was skeptical, Bactrim steet value.
— The online commenting service Disqus released some of its internal research Order Bactrim, showing that pseudonymous commenters tend to leave more and higher-quality comments than their real-name counterparts. GigaOM's Mathew Ingram used the data to argue that a lack of real names isn't nearly as bad as its critics say.
— No real news in SOPA this week, but the text of Cory Doctorow's lecture last month on SOPA and the dangers of copyright regulation has been posted. It's long, but worth a read.
— Finally, three fantastic practical posts on how to practice digital journalism, from big-picture to small-grain: Howard Owens of the Batavian's list of things journalists can do to reinvent journalism, Melanie Sill at Poynter on how to begin doing open journalism, and Steve Buttry of the Journal Register Co. on approaching statehouse coverage from a digital-first perspective.
Similar posts: Armour Cost. Buy Tramadol No Prescription. Order Flagyl. Purchase Armour. Cheap Retin A no rx. Purchase Glucophage for sale.
Trackbacks from: Order Bactrim. Order Bactrim. Order Bactrim. Order Bactrim no prescription. Buy Bactrim from mexico. Bactrim maximum dosage.
[This review was originally posted at the Nieman Journalism Lab Bactrim For Sale, on April 1, 2011.]
Putting the Times' pay plan in place: If you read last week's review, the first half of this week's should feel like déjà vu — lots of back-and-forth about the wisdom of The New York Times' new online pay plan, and some more hand-wringing about getting around that plan. If you want to skip that and get to the best stuff, I recommend Staci Kramer, David Cohn, and Megan Garber.
The Times launched its pay system Monday with a letter to its readers (snarkier version courtesy of Danny Sullivan), along with a 99-cent trial offer for the first four weeks and free access for people who subscribe to the Times on Kindle, Bactrim price. Times digital chief Martin Nisenholtz gave a launch-day talk to newspaper execs, highlighted by his assertion that the link economy is not a win-win for content producers and aggregators.
Meanwhile, the discussion about the paywall's worth rolled on. You can find a good cross-section of opinions in this On Point conversation with Ken Doctor, the Journal Register's John Paton, The Times' David Carr, and NYTClean creator David Hayes, Bactrim For Sale. The plan continues to draw support from some corners, Get Bactrim, including The Onion (in its typically ironic style, of course) and PC Magazine's Lance Ulanoff. Former Financial Times reporter Tom Foremski and Advertising Age columnist Simon Dumenco both made similar arguments about the value of the plan, where can i buy cheapest Bactrim online, with Foremski urging us to support the Times as a moral duty to quality journalism and Dumenco ripping the blogosphere's paywall-bashers for not doing original reporting like the Times.
And though the opposition was expressed much more strongly the past two weeks, there was a smattering of dissent about the plan this week, too — some from the Times' mobile users. One theme among the criticism was the cost of developing the plan: Philip Greenspun wondered how the heck the Times spent $40 million on planning and implementation, and former Guardian digital head Emily Bell wrote about the opportunity cost of that kind of investment. Rx free Bactrim, BNET's Erik Sherman proposed that the Times should have invested the money in innovation instead.
A few other interesting thoughts about the Times' pay plan before we get to the wall-jumping debate: Media consultant Judy Sims said the plan might actually make the Times more social Bactrim For Sale, by providing an incentive for subscribers to share articles on social networks to their non-subscribing friends. Spot.Us' David Cohn argued that the plan is much closer to a donation model than a paywall and argued for the Times to offer membership incentives. And Reuters' Felix Salmon talked about how the proposal is changing blogging at the Times.
PaidContent's Staci Kramer said the Times is fighting an uphill battle in the realm of public perception, but that struggle is the Times' own fault, created by its way-too-complicated pay system.
The ethics of paywall jumping: With the Times' "pay fence" going into effect, Bactrim pictures, all the talk about ways to get around that fence turned into a practical reality. Business Insider compiled seven of the methods that have been suggested: A browser extension, Twitter feeds, using different computers, NYTClean and a User Script's coding magic, Google (for five articles a day), and browser-switching or cookie-deleting, Bactrim For Sale. Mashable came up with an even simpler one: delete "?gwh=numbers" from the Times page's URL.
Despite such easy workarounds, the Times is still cracking down in other areas: As Search Engine Land's Danny Sullivan noted, it blocks links from all Google sites after the five-articles-per-day limit is reached. Bactrim price, coupon, The Times also quickly (and successfully) requested a shutdown of one of the more brazen free-riding schemes yet concocted — NYT for a Nickel, which charged to access Times articles without paywall restrictions. (It did, however, let up on unauthorized Twitter aggregators of Times content.)
So we all obviously can crawl through the Times' loopholes, but should we. A few folks made efforts to hack through the ethical thicket of the Times' intentional and unintentional loopholes: Times media critic James Poniewozik didn't come down anywhere solid Bactrim For Sale, , but said the Times' leaky strategy "makes the paywall something like a glorified tip jar, on a massive scale—something you choose to contribute to without compulsion because it is the right thing" — except unlike those enterprises, it's for-profit. In a more philosophical take, the Lab's Megan Garber said the ethical conundrum shows the difficulty of trying to graft the physical world's ethical assumptions onto the digital world.
A possible +1 for publishers: Google made a big step in the direction of socially driven search this week with the introduction of +1, purchase Bactrim online, a new feature that allows users to vote up certain search results in actions that are visible to their social network. Here are two good explainers of the feature from TechCrunch and Search Engine Land, both of whom note that +1's gold mine is in allowing Google to personalize ads more closely, and that it's starting on search results and eventually moving to sites across the web.
The feature was immediately compared to Facebook's "Like" and Twitter's retweets, Bactrim no rx, though it functions a bit differently from either. As GigaOM's Mathew Ingram noted, because it's Google, it's intrinsically tied to search, which is both an advantage and a disadvantage. As Ingram said, it's smart to add more of a social component to search, but Google's search-centricity makes the "social network" aspect of +1 awkward, just as Buzz and Wave were, Bactrim For Sale. To paraphrase the argument of Frederic Lardinois of NewsGrange: if your +1's go into your Google Profile and no one sees them, do they really make a sound, generic Bactrim.
All this seems to be good news for media sites. Lost Remote's Cory Bergman said that if they essentially become "improve the SEO of this site" buttons, media companies will be pretty motivated to add them to their sites. Likewise, Poynter's Damon Kiesow reasoned that +1 could be a great way for media sites to more deeply involve visitors who arrive via Google, Bactrim duration, who have typically been less engaged than visitors from Facebook and Twitter.
Shrinking innovation to spur it: This month's Carnival of Journalism Bactrim For Sale, focuses on how to drive innovation, specifically through the Knight News Challenge and Reynolds Journalism Institute. Most of the posts rolled in yesterday, and they contain a litany of quick, smart ideas of new directions for news innovation and how to encourage it.
A quick sampling: City University London and Birmingham City University j-prof Paul Bradshaw proposed a much broader, smaller-scale News Challenge fund, with a second fund aimed at making those initiatives scale, where can i buy Bactrim online. J-Lab Jan Schaffer said we need to quit looking at innovation so much solely in terms of tools and more in terms of processes and relationships. British journalist Mary Hamilton and Drury j-prof Jonathan Groves both focused on innovation in training, with Groves proposing "innovation change agents" funded by groups like Knight and the RJI to train and transform newsrooms.
Also, University of British Columbia j-prof Alfred Hermida opined on the role of theory in innovation, Lisa Williams of Placeblogger advocated a small-scale approach to innovation, and the University of Colorado's Steve Outing had some suggestions for the RJI fellowship program, Bactrim For Sale.
The mechanics of Twitter's information flow: Four researchers from Yahoo and Cornell released a study this week analyzing, as they called it, Buy Bactrim no prescription, "who says what to whom on Twitter." One of their major findings was that half the information consumed on Twitter comes from a group of 20,000 "elite" users — media companies, celebrities, organizations and bloggers. As Mathew Ingram of GigaOM observed, that indicates that the power law that governs the blogosphere is also in effect on Twitter, and big brands are still important even on a user-directed platform, Bactrim no prescription.
The Lab's Megan Garber noted a few other interesting implications of the study, delving into Twitter's two-step flow from media to a layer of influential sources to the masses, as well as the social media longevity of multimedia and list-oriented articles. A couple of other research-oriented items about Twitter: A Lab post on Dan Zarrella's data regarding timing and Twitter posts, and Maryland prof Zeynep Tufekci wrote a more theoretical post on NPR's Andy Carvin and the process of news production on Twitter.
Reading roundup: Plenty of other bits and pieces around the future-of-news world this week:
— New York Times editor Bill Keller wrote a second column Bactrim For Sale, , and like his anti-aggregation piece a couple of weeks ago, this piece — about the value of the Times' impartiality and fact-based reporting — didn't go over well. Buy Bactrim without prescription, Reuters' Felix Salmon called him intellectually dishonest, Scott Rosenberg called him defensive, and the Huffington Post's Peter Goodman (a former Times reporter) said Keller misrepresented him.
— A few notes on The Daily: Forbes' Jeff Bercovici said it was downloaded 500,000 times during its trial period and has 70,000 regular users, and a study was conducted finding that it's more popular with less tech-savvy, purchase Bactrim for sale, less content-concerned users.
— Journal Register Co. CEO John Paton talked about transforming newspapers at the Newspaper Association of America convention; he summarized what he had to say in 10 tweets, and Alan Mutter wrote a post about the panel. The moderator, Ken Doctor, wrote a Lab post looking at how long newspapers have left.
— I'll send you off with Jonathan Stray's thoughtful post on rethinking journalism as a system for informing people, rather than just a series of stories. It's a lot to chew on, but a key piece to add to the future-of-news puzzle.
Similar posts: Buy Tramadol No Prescription. Order Flagyl. Tramadol Over The Counter. Purchase Armour. Cheap Retin A no rx. Purchase Glucophage for sale.
Trackbacks from: Bactrim For Sale. Bactrim For Sale. Bactrim For Sale. Bactrim dosage. Ordering Bactrim online. Buy cheap Bactrim no rx.